Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia

por Kubicka, Ewa, Lum, Lawrence G., Huang, Manley, Thakur, Archana
Publicado 2022

Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1(+) Myeloma Cells and Release Type-1 Cytokines

por Lum, Lawrence G., Thakur, Archana, Elhakiem, Abdalla, Alameer, Lena, Dinning, Emily, Huang, Manley
Publicado 2020

Enhanced immunogenicity of a functional enzyme by T cell epitope modification

por Mucha, Jeanette M, Stickler, Marcia M, Poulose, AJ, Ganshaw, Grant, Saldajeno, Mae, Collier, Kathy, Huang, Manley T, Harding, Fiona A
Publicado 2002

Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours

por Huang, Manley T. F., Sharma, Vikram, Mendelsohn, Andrew, Wei, Qisheng, Li, Jinjing, Yu, Bo, Larrick, James W., Lum, Lawrence G.
Publicado 2022

Targeted In Vivo Extracellular Matrix Formation Promotes Neovascularization in a Rodent Model of Myocardial Infarction

por Mihardja, Shirley S., Gao, Dongwei, Sievers, Richard E., Fang, Qizhi, Feng, Jinjin, Wang, Jianming, Vanbrocklin, Henry F., Larrick, James W., Huang, Manley, Dae, Michael, Lee, Randall J.
Publicado 2010